Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system

British Journal of Pharmacology
Jane A Mitchell, Nicholas S Kirkby

Abstract

Eicosanoids represent a diverse family of lipid mediators with fundamental roles in physiology and disease. Within the eicosanoid superfamily are prostanoids, which are specifically derived from arachidonic acid by the enzyme cyclooxygenase (COX). COX has two isoforms; COX-1 and COX-2. COX-2 is the therapeutic target for the nonsteroidal anti-inflammatory drug (NSAID) class of pain medications. Of the prostanoids, prostacyclin, first discovered by Sir John Vane in 1976, remains amongst the best studied and retains an impressive pedigree as one of the fundamental cardiovascular protective pathways. Since this time, we have learnt much about how eicosanoids, COX enzymes and prostacyclin function in the cardiovascular system, knowledge that has allowed us, for example, to harness the power of prostacyclin as therapy to treat pulmonary arterial hypertension and peripheral vascular disease. However, there remain many unanswered questions in our basic understanding of the pathways, and how they can be used to improve human health. Perhaps, the most important and controversial outstanding question in the field remains; 'how do NSAIDs produce their much publicized cardiovascular side-effects?' This review summarizes the history, biolog...Continue Reading

References

Jul 1, 1977·Lipids·M E Hemler, W E Lands
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T Hla, K Neilson
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·W L XieD L Simmons
Jul 1, 1991·Journal of Clinical Pharmacology·A Whelton, C W Hamilton
Nov 15, 1989·Biochemical and Biophysical Research Communications·G D RosenM J Holtzman
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D L DeWitt, W L Smith
Oct 1, 1984·Circulation·P J Cannon
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J R VaneD A Willoughby
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A MitchellJ R Vane
Apr 1, 1997·British Journal of Pharmacology·K B JourdanJ A Mitchell
May 1, 1997·British Journal of Pharmacology·D Bishop-BaileyJ A Mitchell
Nov 27, 1998·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J A Mitchell, T W Evans
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Dec 26, 2001·Chemical Reviews·J B Shabb
Feb 17, 2005·The New England Journal of Medicine·Robert S BresalierUNKNOWN Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xinmin ZhangMarc Montminy
Feb 18, 2006·Nature Reviews. Drug Discovery·Jane A Mitchell, Timothy D Warner
Apr 15, 2006·The Journal of Clinical Investigation·Yan ChengGarret A Fitzgerald
Jun 21, 2006·Journal of Cardiovascular Pharmacology·Raymond C Harris
Sep 1, 2006·The New England Journal of Medicine·Monica M BertagnolliUNKNOWN APC Study Investigators
Nov 8, 2006·Gastroenterology·John A BaronUNKNOWN APPROVe Trial Investigators
Feb 6, 2007·Trends in Pharmacological Sciences·Nicholas A Flavahan
Nov 22, 2007·Journal of Cardiovascular Pharmacology·Colin D Funk, Garret A FitzGerald
May 31, 2008·Circulation Research·Tongrong HeZvonimir S Katusic
Nov 18, 2008·Journal of Lipid Research·John E Burke, Edward A Dennis
Jan 20, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Ferhana Y AliTimothy D Warner
Sep 22, 2009·Expert Review of Cardiovascular Therapy·Domenico Praticò, Jean-Michel Dogné
Dec 28, 2010·Progress in Lipid Research·Makoto MurakamiKei Yamamoto
Jan 13, 2011·BMJ : British Medical Journal·Sven TrellePeter Jüni
Oct 25, 2011·American Journal of Respiratory Cell and Molecular Biology·Yingji LiAndrea Olschewski
May 4, 2012·Science Translational Medicine·Ying YuGarret A FitzGerald
Oct 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nicholas S KirkbyJane A Mitchell

❮ Previous
Next ❯

Citations

Mar 8, 2018·British Journal of Pharmacology·Marilena CrescenteTimothy D Warner
Apr 7, 2019·British Journal of Pharmacology·Roderick J Flower
Apr 12, 2019·Circulation·Matti MarklundUNKNOWN Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE)
Nov 14, 2019·British Journal of Pharmacology·Nikolaos TzoumasDavid J Webb
Jul 4, 2020·Essays in Biochemistry·William W Christie, John L Harwood
Sep 26, 2020·Journal of the American Heart Association·Joonatan PalmuTeemu J Niiranen
Nov 7, 2019·Cardiovascular Research·Nicholas S KirkbyJane A Mitchell
Mar 28, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·R Preston MasonDeepak L Bhatt
Jul 10, 2020·Antioxidants & Redox Signaling·Erica GianazzaCristina Banfi
Aug 18, 2020·British Journal of Clinical Pharmacology·Ricky VajaJane A Mitchell
Oct 27, 2018·International Journal of Molecular Sciences·Thomas SonnweberIvan Tancevski
May 18, 2019·Nature Reviews. Cardiology·Jason H Y WuDariush Mozaffarian
Nov 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Diego AraunaIván Palomo
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Blerina Ahmetaj-ShalaJane A Mitchell
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Martina Cebova, Olga Pechanova
Jan 10, 2019·World Journal of Gastroenterology : WJG·Rafael I JaénLisardo Boscá
Oct 31, 2020·International Journal of Molecular Sciences·Matthias WeiderLina Gölz
Dec 3, 2020·International Journal of Molecular Sciences·Steffen BrauneFriedrich Jung
Feb 24, 2021·Current Opinion in Obstetrics & Gynecology·Andrew R MatherLoralei L Thorburg
Feb 28, 2021·Signal Transduction and Targeted Therapy·Bei WangDao Wen Wang
Jul 9, 2020·Pharmacology & Therapeutics·Jane A MitchellTimothy D Warner
Mar 27, 2021·Vascular Pharmacology·Esteban G FigueroaEmilio A Herrera
Mar 23, 2021·Cardiovascular Research·Katherine A MurphyTimothy D O'Connell
Nov 14, 2020·International Journal of Molecular Sciences·Ken YasukawaTakehiko Yokomizo
May 21, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wentao ChenLuzheng Xue
May 14, 2021·The Journal of Clinical Endocrinology and Metabolism·Kai WangKe Yao
Jul 30, 2021·The Science of the Total Environment·E LawtonE J Routledge
Sep 1, 2021·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Samuel C R SherrattR Preston Mason

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase

Software Mentioned

PRECISION

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Annual Review of Medicine
Marco E Turini, Raymond N DuBois
Current Drug Targets. Inflammation and Allergy
Candace D Poff, Michael Balazy
Methods and Findings in Experimental and Clinical Pharmacology
S K KulkarniA Singh
© 2022 Meta ULC. All rights reserved